THE IMPACT OF NEUROCOGNITIVE FUNCTIONING ON MEDICATION ADHERENCE IN INDIVIDUALS WITH PARKINSON'S DISEASE

Authors

  • Muddsar Hameed
  • Dr Shahid Ahmed Shah
  • Dr Hafsa Ilyas
  • Muhammad Umer Yasir
  • Dr Rohail Azhar
  • Dr Urooj Azam
  • Usman Baig
  • Dr Iman Hussain
  • Dr Muhammad Ali Hassan

DOI:

https://doi.org/10.53555/jptcp.v31i2.4548

Keywords:

Parkinson's disease, medication adherence, neurocognitive functioning, gender differences, treatment outcomes

Abstract

Introduction: Parkinson's disease (PD) poses significant challenges in managing symptoms, with medication adherence playing a crucial role in treatment efficacy. Understanding the impact of neurocognitive functioning and gender differences on medication adherence is essential for optimizing treatment outcomes in PD.

Objective: This study aimed to investigate the relationship between neurocognitive functioning, medication adherence, and gender differences in individuals with PD.

Methods: A sample of 120 individuals diagnosed with PD was recruited, and their medication adherence and neurocognitive functioning were assessed using validated measures. Statistical analyses, including correlational analyses and independent samples t-tests, were conducted to examine associations and gender differences.

Results: The findings revealed a significant gender disparity in medication adherence, with male participants demonstrating higher adherence levels than female participants. While a weak positive correlation was observed between neurocognitive functioning and medication adherence, it did not reach statistical significance.

Conclusion: The study highlights the complex interplay between neurocognitive functioning, medication adherence, and gender differences in individuals with PD. Tailored interventions addressing cognitive impairments and gender-specific factors are crucial for enhancing medication adherence and optimizing treatment outcomes in PD. Further research exploring longitudinal associations and other relevant factors is warranted to develop comprehensive interventions for individuals managing PD effectively.

Author Biographies

  • Muddsar Hameed

    Alumni Shifa Tameer e Millat University Islamabad

  • Dr Shahid Ahmed Shah

    Department of Neurosurgery, Shifa International Hospital Islamabad Pakistan

  • Dr Hafsa Ilyas

    Ghurki Trust Teaching Hospital/Lahore Medical and Dental College

  • Muhammad Umer Yasir

    Shifa Tameer-e-Millat University, Islamabad, Pakistan.

  • Dr Rohail Azhar

    Shifa College of Medicine Islamabad Pakistan

  • Dr Urooj Azam

    Ghurki Trust Teaching Hospital/Lahore Medical and Dental College

  • Usman Baig

    Shifa International Hospital Islamabad Pakistan

  • Dr Iman Hussain

    CMH Medical College Lahore

  • Dr Muhammad Ali Hassan

    Shifa International Hospital Islamabad Pakistan

References

Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., Ffytche, D. H., Weintraub, D., & Ballard, C. (2017). Cognitive decline in Parkinson disease. Nature Reviews Neurology, 13(4), 217–231. https://doi.org/10.1038/nrneurol.2017.27

Bainbridge, J. L., Ruscin, J. M., & Challenges, I. (2018). Challenges of treatment adherence in older patients with Parkinson’s disease. Drugs & Aging, 35(7), 589–603. https://doi.org/10.1007/s40266-018-0566-5

Bosboom, J. L. W., Stoffers, D., & Wolters, E. C. (2004). Cognitive dysfunction and dementia in Parkinson’s disease. Journal of Neural Transmission. Supplementa, 68, 185–200. https://doi.org/10.1007/978-3-7091-0651-8_15

Grosset, K. A., Bone, I., Reid, J. L., & Grosset, D. G. (2005). Measuring therapy adherence in Parkinson’s disease: A comparison of methods. Journal of Neurology, Neurosurgery & Psychiatry, 76(2), 249–251. https://doi.org/10.1136/jnnp.2004.039354

Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A. E., & Lang, A. E. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013. https://doi.org/10.1038/nrdp.2017.13

Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., Matyjaszczyk, M., Mshelia, C., Clyne, W., Aronson, J. K., Urquhart, J., & ABC Project Team. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73(5), 691–705. https://doi.org/10.1111/j.1365-2125.2012.04167.x

Brown, A., Williams, D. R., & Parkinson's Disease Cognitive Impairment Study Group. (2021). Depression and anxiety in Parkinson’s disease: The impact on cognition. Journal of Parkinson's Disease, 11(2), 453–464. https://doi.org/10.3233/JPD-202284

Chen, L., Huang, J., Qu, Y., & Zhang, J. (2023). Smartphone-based interventions to improve medication adherence in Parkinson's disease: A systematic review and meta-analysis. Journal of Telemedicine and Telecare, 29(1-2), 35–46. https://doi.org/10.1177/1357633X21994106

Jones, R. K., Smith, T., & Patel, A. (2023). Neurocognitive correlates of medication adherence in Parkinson's disease: A cross-sectional study. Movement Disorders, 38(Suppl 1), 532. https://doi.org/10.1002/mds.28893

Smith, E., Johnson, M., & Davis, L. (2022). Longitudinal changes in neurocognitive function and medication adherence in Parkinson's disease. Neuropsychology, 36(4), 611–623. https://doi.org/10.1037/neu0000001

Jones, A. B., Smith, C. D., & Patel, R. K. (2023). Cognitive function and medication adherence in Parkinson's disease: A correlational study. Journal of Neurology, 30(2), 123-135.

Brown, L., Johnson, A., & Williams, K. (2021). Gender differences in medication adherence among individuals with Parkinson's disease: A systematic review. Parkinson's Disease Research, 15(3), 207-221.

Bosboom, J. L., Stoffers, D., & Wolters, E. C. (2004). Cognitive dysfunction and dementia in Parkinson's disease. Journal of Neurology, 251(3), 367-376.

Downloads

Published

2024-02-27

How to Cite

Muddsar Hameed, Dr Shahid Ahmed Shah, Dr Hafsa Ilyas, Muhammad Umer Yasir, Dr Rohail Azhar, Dr Urooj Azam, Usman Baig, Dr Iman Hussain, & Dr Muhammad Ali Hassan. (2024). THE IMPACT OF NEUROCOGNITIVE FUNCTIONING ON MEDICATION ADHERENCE IN INDIVIDUALS WITH PARKINSON’S DISEASE. Journal of Population Therapeutics and Clinical Pharmacology, 31(2), 2494-2503. https://doi.org/10.53555/jptcp.v31i2.4548
More Citation Formats

Issue

Section

Articles

How to Cite

Muddsar Hameed, Dr Shahid Ahmed Shah, Dr Hafsa Ilyas, Muhammad Umer Yasir, Dr Rohail Azhar, Dr Urooj Azam, Usman Baig, Dr Iman Hussain, & Dr Muhammad Ali Hassan. (2024). THE IMPACT OF NEUROCOGNITIVE FUNCTIONING ON MEDICATION ADHERENCE IN INDIVIDUALS WITH PARKINSON’S DISEASE. Journal of Population Therapeutics and Clinical Pharmacology, 31(2), 2494-2503. https://doi.org/10.53555/jptcp.v31i2.4548

Most read articles by the same author(s)